BU CAMED attracts some of the most distinguished and highly accomplished faculty in the biomedical sciences field. All are dedicated to GMS’ academic and clinical missions. BU CAMED has 1,159 faculty members, of whom 946 are full-time and 213 are part-time. Of the fulltime faculty, 300 are Division of Graduate Medical Sciences faculty. Basic science faculty members perform cutting-edge research and clinical faculty members treat diverse patient populations and provide patient-centered training. Research BU CAMED is home to one of the largest and most rapidly growing research programs at a U.S. medical school. More than 600 funded research programs that total more than $180 million (per year) in NIH support provide an exceptional environment for students interested in basic science, clinical investigation, or public health and health services oriented research.

The many research efforts at BU CAMED include the following:

  • The National Emerging Infectious Diseases Laboratories (NEIDL), which represents a major step forward at BU CAMED in advancing public health and biomedical research.
  • The biocontainment laboratory has been developed in partnership with the National Institute of Allergy and Infectious Diseases. Its mission is to develop diagnostic drugs, vaccines and treatments to prevent and cure life-threatening infectious diseases. A state-of-the-art BS Level 4 Laboratory is housed within this 194,000 square foot facility.
  • Neuroimaging research at BU CAMED has accelerated recently with the Center for Biomedical Imaging’s addition of a 3 Tesla Philips MRI scanner for human and animal functional, structural, and spectroscopic studies.
  • The Alzheimer’s Disease Neuroimaging Initiate (ADNI), a $60 million, 5-year public-private partnership overseen by the National Institute of Aging. The ADNI study plans to enroll 800 participants nationwide to test whether magnetic resonance imaging (MRI), positron emission tomography (PET) and other clinical and neuropsychological measures can be combined to better understand the progression of Alzheimer’s disease.
  • The Framingham Heart Study, which has been administered by BU CAMED faculty in cooperation with National Heart, Lung and Blood Institute since 1971, was initiated in 1948 to identify factors contributing to cardiovascular disease, principally heart attack and stroke. The principal investigators and the project directors of the Framingham Heart Study have all been BU CAMED faculty.